To improve the clinical diagnosis of pneumococcal infection in bacteremic and nonbacteremic community-acquired pneumonia (CAP), a Luminex technology-based multiplex urinary antigen detection (UAD) diagnostic assay was developed and validated. The UAD assay is a limit assay based on defined
No takes yet. Share an insight, caveat, or question.
Pride et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: